Ohcanbohtosat - Scholand, Mary Beth
- Čájehuvvo 1 - 20 / 31
- Sirdás čuovvovaš siidui
-
1
Genetic Discovery, Rigorous Statistics, and Pandemic Influenza Dahkki Scholand, Mary Beth, Liou, Theodore G.
Almmustuhtton 2014Teaksta -
2
Patient-reported outcome measures in systemic sclerosis–related interstitial lung disease for clinical practice and clinical trials Dahkki Saketkoo, Lesley Ann, Scholand, Mary Beth, Lammi, Matthew R., Russell, Anne-Marie
Almmustuhtton 2020Teaksta -
3
-
4
Short-Term Particulate Air Pollution Exposure is Associated with Increased Severity of Respiratory and Quality of Life Symptoms in Patients with Fibrotic Sarcoidosis Dahkki Pirozzi, Cheryl S., Mendoza, Daniel L., Xu, Yizhe, Zhang, Yue, Scholand, Mary Beth, Baughman, Robert P.
Almmustuhtton 2018Teaksta -
5
-
6
Effect of Naturally Occurring Ozone Air Pollution Episodes on Pulmonary Oxidative Stress and Inflammation Dahkki Pirozzi, Cheryl, Sturrock, Anne, Weng, Hsin-Yi, Greene, Tom, Scholand, Mary Beth, Kanner, Richard, Paine, Robert
Almmustuhtton 2015Teaksta -
7
Can routine use of patient reported outcomes help guide systemic sclerosis chronic disease care? Dahkki Frech, Tracy M., Hess, Rachel, Biber, Joshua, Young, Jeff, Hardman, Alexander, Weeks, Howard, Peterson, Kathyrn A., Scholand, Mary Beth
Almmustuhtton 2018Teaksta -
8
High-Sensitivity NanoLC—MS/MS Analysis of Urinary Desmosine and Isodesmosine Dahkki Boutin, Michel, Berthelette, Carl, Gervais, François G., Scholand, Mary-Beth, Hoidal, John, Leppert, Mark F., Bateman, Kevin P., Thibault, Pierre
Almmustuhtton 2009Teaksta -
9
Severity of cough in idiopathic pulmonary fibrosis is associated with MUC5 B genotype Dahkki Scholand, Mary Beth, Wolff, Roger, Crossno, Peter Fredrick, Sundar, Krishna, Winegar, Molly, Whipple, Spencer, Carey, Patrick, Sunchild, Nicholas, Coon, Hilary
Almmustuhtton 2014Teaksta -
10
Polymorphisms in key pulmonary inflammatory pathways and the development of acute respiratory distress syndrome Dahkki Brown, Samuel M., Grissom, Colin K., Rondina, Matthew T., Hoidal, John R., Scholand, Mary Beth, Wolff, Roger K., Morris, Alan H., Paine, Robert
Almmustuhtton 2014Teaksta -
11
Development and Initial Validation Analyses of the Living with Idiopathic Pulmonary Fibrosis Questionnaire Dahkki Swigris, Jeffrey J., Andrae, David A., Churney, Tara, Johnson, Nathan, Scholand, Mary Beth, White, Eric S., Matsui, Alison, Raimundo, Karina, Evans, Christopher J.
Almmustuhtton 2020Teaksta -
12
An ode to the primal tonic of dance—congratulating the Life of Breath project Dahkki Saketkoo, Lesley Ann, Alexanderson, Helene, Lammi, Matthew R, LeSage, Daphne, Jensen, Kelly, Scholand, Mary Beth, Volkmann, Elizabeth R, Russell, Anne-Marie
Almmustuhtton 2020Teaksta -
13
Low-Dose Naltrexone for Pruritus in Systemic Sclerosis Dahkki Frech, Tracy, Novak, Kirsten, Revelo, Monica P., Murtaugh, Maureen, Markewitz, Boaz, Hatton, Nathan, Scholand, Mary Beth, Frech, Edward, Markewitz, David, Sawitzke, Allen D.
Almmustuhtton 2011Teaksta -
14
Chronic Multiorgan Rare Disease: The Role of the Nurse Practitioner as a Leader of the Healthcare Team Dahkki Allred, Deanna, Frech, Tracy M., McComber, Cynthia, Peterson, Kathryn, Ortiz, Gloria, McNeill, Constance, Broadbent, Linsey, Elorreaga, Nancy, Miller, Thomas, Scholand, Mary Beth
Almmustuhtton 2017Teaksta -
15
Smoking, COPD, and 3-Nitrotyrosine Levels of Plasma Proteins Dahkki Jin, Hongjun, Webb-Robertson, Bobbie-Jo, Peterson, Elena S., Tan, Ruimin, Bigelow, Diana J., Scholand, Mary Beth, Hoidal, John R., Pounds, Joel G., Zangar, Richard C.
Almmustuhtton 2011Teaksta -
16
Phase 2 trial to assess lebrikizumab in patients with idiopathic pulmonary fibrosis Dahkki Maher, Toby M., Costabel, Ulrich, Glassberg, Marilyn K., Kondoh, Yasuhiro, Ogura, Takashi, Scholand, Mary Beth, Kardatzke, David, Howard, Monet, Olsson, Julie, Neighbors, Margaret, Belloni, Paula, Swigris, Jeffrey J.
Almmustuhtton 2021Teaksta -
17
Expert consensus on the management of adverse events and prescribing practices associated with the treatment of patients taking pirfenidone for idiopathic pulmonary fibrosis: a Del... Dahkki Rahaghi, Franck F., Safdar, Zeenat, Brown, Anne Whitney, de Andrade, Joao A., Flaherty, Kevin R., Kaner, Robert J., King, Christopher S., Padilla, Maria L., Noth, Imre, Scholand, Mary Beth, Shifren, Adrian, Nathan, Steven D.
Almmustuhtton 2020Teaksta -
18
Sarcoidosis Illuminations on Living During COVID-19: Patient Experiences of Diagnosis, Management, and Survival Before and During the Pandemic * Dahkki Saketkoo, Lesley Ann, Jensen, Kelly, Nikoletou, Dimitra, Newton, Jacqui J., Rivera, Frank J., Howie, Mike, Reese, Rodney K., Goodman, Melanie, Hart, Patricia B., Bembry, Whitney, Russell, Adam, Lian, Isabelle, Lammi, Matthew R., Scholand, Mary Beth, Russell, Anne-Marie
Almmustuhtton 2022Teaksta -
19
Airway PI3K Pathway Activation Is an Early and Reversible Event in Lung Cancer Development Dahkki Gustafson, Adam M., Soldi, Raffaella, Anderlind, Christina, Scholand, Mary Beth, Qian, Jun, Zhang, Xiaohui, Cooper, Kendal, Walker, Darren, McWilliams, Annette, Liu, Gang, Szabo, Eva, Brody, Jerome, Massion, Pierre P., Lenburg, Marc E., Lam, Stephen, Bild, Andrea H., Spira, Avrum
Almmustuhtton 2010Teaksta -
20
A Semiautomated Framework for Integrating Expert Knowledge into Disease Marker Identification Dahkki Wang, Jing, Webb-Robertson, Bobbie-Jo M., Matzke, Melissa M., Varnum, Susan M., Brown, Joseph N., Riensche, Roderick M., Adkins, Joshua N., Jacobs, Jon M., Hoidal, John R., Scholand, Mary Beth, Pounds, Joel G., Blackburn, Michael R., Rodland, Karin D., McDermott, Jason E.
Almmustuhtton 2013Teaksta